City Therapeutics, Inc. (CTY) stock analysis
CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.98+1.97 (+11.58%)
Close on Nov 12, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for City Therapeutics.
See a number that looks wrong?